UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): August 10, 2020

 

Genasys Inc.

(Exact name of registrant as specified in its charter)

 

          Delaware          

        000-24248       

     87-0361799     

(State or Other Jurisdiction of

Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 

16262 West Bernardo Drive

San Diego, California 92127

(Address of Principal Executive Offices)

 


 

858-676-1112

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14.a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $.00001 par value per share

GNSS

NASDAQ Capital Market

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

On August 10, 2020, the Company issued a press release regarding its financial results for the fiscal second quarter ended June 30, 2020. A copy of the press release is furnished as Exhibit 99.1 hereto, and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits

 

(d)           Exhibits.

 

99.1

Financial Results Press Release, dated August 10, 2020, issued by the Company.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: August 10, 2020

  Genasys Inc.  
       
  By: /s/ Dennis D. Klahn  
    Dennis D. Klahn  
    Chief Financial Officer  

 

 
ex_198508.htm

Exhibit 99.1

 

 

Genasys™ Inc. Reports Fiscal Third Quarter 2020 Financial Results

 

SAN DIEGO, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions, today announced record fiscal third quarter revenues in its financial results for the period ended June 30, 2020.

 

Fiscal Third Quarter 2020 Financial Summary

 

Fiscal 2020 third quarter revenues were $12.0 million, an increase of 35% from $8.9 million in the same period last year, and the highest revenue in any third quarter in the Company's history. The increase in revenues was due to a larger backlog and the timing of deliveries in backlog as of March 31, 2020, as compared to March 31, 2019.   

 

Gross profit margin was 54.1%, compared with 51.9% in the third quarter of fiscal 2019. Gross profit increased primarily due to higher revenues, which further leveraged the Company's fixed operating expenses.

 

Operating expenses were $4.5 million, an increase of 16% from $3.9 million in the same period a year ago. The increase was primarily due to higher selling, general and administrative expenses to support the higher revenue and future revenue growth opportunities.

 

Net income in the quarter was $1.5 million, or $0.04 per diluted share, compared with $0.6 million, or $0.02 per diluted share, in the third quarter of fiscal 2019.

 

Cash and cash equivalents totaled $20.7 million on June 30, 2020, up from $16.4 million on March 31, 2020, and $18.8 million on September 30, 2019.

 

Working capital totaled $26.9 million on June 30, 2020, compared with $24.8 million on September 30, 2019.

 

“Record fiscal third quarter revenues were driven by a 115% increase in acoustic hailing device (“AHD”) revenues, as compared with the same period last year,” said Richard S. Danforth, Chief Executive Officer of Genasys Inc. “Bookings for the quarter were $22.7 million, an increase of 118% from fiscal third quarter 2019 bookings. Backlog at June 30, 2020 also increased to $26.4 million. Strong fiscal third quarter bookings and backlog have the Company on track for record fiscal year revenues.”

 

 

 

First Nine Months Financial Summary

 

Revenues for the first nine months of fiscal 2020 were $29.0 million, compared with $29.2 million in the same period last year. 

 

Gross profit margin was 52.0%, compared with 50.9% the first nine months of fiscal 2019. Gross profit increased primarily due to a better mix of revenue.

 

Operating expenses were $12.1 million, an increase of 6% from $11.5 million in the same period a year ago. The increase was primarily due to higher selling, general and administrative expenses.

 

Net income for the first nine months was $2.4 million, or $0.07 per diluted share, compared with $2.9 million, or $0.09 per diluted share, in the first nine months of fiscal 2019. The decrease was primarily due to higher operating expenses in the current year to date period.

 

Select Fiscal Third Quarter 2020 Operating and Business Highlights

 

 

Announced $14.5 million in U.S. Army follow-on AHD orders

 

 

Received $4.3 million U.S. Navy IDIQ AHD contract

 

 

Donated Genasys Personal Safety Service software module to help unify the Salvation Army Western Territory's COVID-19 response  

 

 

Announced $3.9 million in international naval, border, port and homeland security orders

 

 

Received $1.4 million in AHD orders for U.S. military and government agencies             

 

 

Became an official Federal Emergency Management Agency IPAWS-OPEN software service provider

 

 

Presented webinars outlining the Company’s National Emergency Warning System (“NEWS”) solution for the June 2022 European Emergency Warning directive (EECC, Article 110)

 

“The entire Genasys team has done a terrific job to help position the Company for another fiscal year of record revenues in spite of unprecedented headwinds from the COVID-19 pandemic,” Mr. Danforth added. “As announced earlier today, using our strong balance sheet to acquire enterprise software service provider, Amika Mobile, is expected to strengthen our Software-as-a-Service (“SaaS”) business and extend our products into large enterprise vertical markets.”  

 

“We are pursuing additional acquisitions of complementary products, services and technology that will further augment our SaaS business,” continued Mr. Danforth. “By enhancing our SaaS product offerings and expanding our addressable markets, we plan to accelerate revenue growth and maximize shareholder value.”

 

We include in this press release Non-GAAP operational metrics of bookings and backlog, which we believe provide helpful information to investors with respect to evaluating the Company’s performance. We consider bookings and backlog as leading indicators of future revenues and use these metrics to support production planning. Bookings is an internal, operational metric that measures the total dollar value of customer purchase orders executed in a period, regardless of the timing of the related revenue recognition. Backlog is a measure of purchase orders received that have not been shipped but are planned to ship within the next 12 months.

 

 

 

Webcast and Conference Call Details

 

Management will host a conference call to discuss the fiscal third quarter 2020 financial results this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (862) 298-0702. A webcast will also be available at the following link:
https://www.webcaster4.com/Webcast/Page/1375/35822.

 

Questions to management may be submitted before the call by emailing them to: ir@genasys.com. A replay of the webcast will be available approximately four hours after the presentation on the Events & Presentations page of the Company’s website. 

 

About Genasys Inc.
Genasys is a global provider of critical communications systems and solutions to help keep people safe. Genasys provides a multi-channel approach to deliver geo-targeted alerts, notifications, instructions and information before, during and after public safety threats and critical business events. The Company’s unified critical communications platform includes its National Emergency Warning System (NEWS), Personal Safety Service (PSS), Team Safety Management (TSM), LRAD® voice broadcast systems and more.

 

Genasys systems are in service in 72 countries and in more than 450 U.S. cities in diverse applications, including public safety, emergency warning, mass notification, critical event management, defense, law enforcement, homeland security and many more. For more information, visit genasys.com.

 

Forward-Looking Statements

 

Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties, including without limitation the failure of the proposed Amika Mobile transaction to close on the expected timeline or at all; the effect of the Amika Mobile announcement of the transaction on customer relationships and operating results; the ability to meet all closing conditions to the Amika Mobile transaction; and the business impact of health crises or outbreaks of disease, such as epidemics or pandemics, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management’s expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the “Risk Factors” section of the Company’s Form 10-K for the fiscal year ended September 30, 2019. Genasys Inc. disclaims any intent or obligation to update those forward-looking statements, except as otherwise specifically stated.

 

Investor Relations Contacts

 

Jim Fanucchi and Satya Chillara
Darrow Associates, Inc.
ir@genasys.com

 

 

 

Genasys Inc.

Condensed Consolidated Balance Sheets

(000's omitted)

 

   

June 30,

         
   

2020

   

September 30,

 
   

(unaudited)

   

2019

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 20,668     $ 18,819  

Short-term marketable securities

    4,054       3,695  

Restricted cash

    271       263  

Accounts receivable, net

    6,378       3,644  

Inventories, net

    7,334       5,835  

Prepaid expenses and other

    1,053       1,782  

Total current assets

    39,758       34,038  

Long-term marketable securities

    3,337       1,385  

Long-term restricted cash

    395       435  

Deferred tax assets, net

    4,645       5,387  

Property and equipment, net

    1,985       2,269  

Goodwill

    2,371       2,306  

Intangible assets, net

    981       1,176  

Operating lease right of use asset

    5,428       -  

Prepaid expenses and other - noncurrent

    124       124  

Total assets

  $ 59,024     $ 47,120  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Accounts payable

  $ 2,907     $ 860  

Accrued liabilities

    8,883       8,134  

Notes payable, current portion

    288       280  

Operating lease liabilities, current portion

    752       -  

Total current liabilities

    12,830       9,274  
                 

Notes payable, less current portion

    17       33  

Other liabilities, noncurrent

    384       2,432  

Operating lease liabilities, noncurrent

    6,586       -  

Total liabilities

    19,817       11,739  
                 

Total stockholders' equity

    39,207       35,381  

Total liabilities and stockholders' equity

  $ 59,024     $ 47,120  

 

 

 

Genasys Inc.

Condensed Consolidated Statements of Operations

(000's omitted except share and per share amounts)

(Unaudited)

 

   

Three months ended

   

Nine months ended

 
   

June 30,

   

June 30,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Revenues

  $ 11,971     $ 8,864     $ 29,029     $ 29,233  

Cost of revenues

    5,500       4,262       13,946       14,351  

Gross profit

    6,471       4,602       15,083       14,882  
                                 

Operating expenses:

                               

Selling, general and administrative

    3,330       2,713       8,884       7,939  

Research and development

    1,200       1,203       3,233       3,531  

Total operating expenses

    4,530       3,916       12,117       11,470  
                                 

Income from operations

    1,941       686       2,966       3,412  

Other income and expense, net

    36       70       202       126  

Income before income taxes

    1,977       756       3,168       3,538  

Income tax expense

    473       118       742       675  

Net income

  $ 1,504     $ 638     $ 2,426     $ 2,863  
                                 

Net income per common share:

                               

Basic

  $ 0.05     $ 0.02     $ 0.07     $ 0.09  

Diluted

  $ 0.04     $ 0.02     $ 0.07     $ 0.09  
                                 

Weighted average common shares outstanding:

                               

Basic

    33,289,426       32,575,118       33,122,042       32,684,311  

Diluted

    34,280,915       33,372,777       33,878,243       33,341,057